Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive (Mail Code 7764), San Antonio, TX, 78229, USA; Addiction Research, Treatment and Training (ARTT) Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive (Mail Code 7764), San Antonio, TX, 78229, USA; Addiction Research, Treatment and Training (ARTT) Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Drug Alcohol Depend. 2021 Apr 1;221:108599. doi: 10.1016/j.drugalcdep.2021.108599. Epub 2021 Feb 13.
A significant number of deaths caused by opioids involve fentanyl and/or one of its very potent analogs (e.g., carfentanil). Some clinical reports suggest larger doses of opioid receptor antagonists may be required to reverse the effects of carfentanil compared with other opioid receptor agonists, although this has not been examined extensively in vivo. The current study compared the discriminative stimulus effects of fentanyl, carfentanil, and heroin, and their antagonism by naltrexone.
Eight male Sprague-Dawley rats were trained to discriminate 10.0 μg/kg fentanyl from saline while responding under a fixed-ratio 10 schedule of food presentation. Dose-effect curves were determined for the opioid receptor agonists fentanyl (1.0-32.0 μg/kg), carfentanil (0.1-3.2 μg/kg), and heroin (10.0-320.0 μg/kg), then redetermined following a 15-minute pretreatment with 0.1 mg/kg naltrexone.
Fentanyl, carfentanil, and heroin dose-dependently increased responding on the fentanyl-associated lever and decreased the rate of lever pressing. Carfentanil and heroin were approximately 10-fold more and less potent, respectively, than fentanyl at eliciting >80 % responding on the fentanyl-associated lever. Pretreatment with 0.1 mg/kg naltrexone resulted in a significant rightward shift in the fentanyl and heroin but not carfentanil dose-effect curves.
Differences in the effectiveness of naltrexone to attenuate the discriminative stimulus effects of carfentanil, compared with fentanyl and heroin, suggest that there may be differences in how carfentanil exerts its discriminative stimulus effects compared with other opioids. Further evaluation is needed of potential pharmacological and behavioral differences between carfentanil and other opioids, particularly in the context of toxicity.
大量阿片类药物致死事件涉及芬太尼和/或其一种非常有效的类似物(例如,卡芬太尼)。一些临床报告表明,与其他阿片受体激动剂相比,可能需要更大剂量的阿片受体拮抗剂来逆转卡芬太尼的作用,尽管这尚未在体内进行广泛研究。本研究比较了芬太尼、卡芬太尼和海洛因的辨别刺激作用及其对纳曲酮的拮抗作用。
8 只雄性 Sprague-Dawley 大鼠接受训练,以辨别 10.0 μg/kg 芬太尼与生理盐水,同时在固定比率 10 次食物呈现的条件下进行反应。确定了阿片受体激动剂芬太尼(1.0-32.0 μg/kg)、卡芬太尼(0.1-3.2 μg/kg)和海洛因(10.0-320.0 μg/kg)的剂量-效应曲线,然后在 0.1 mg/kg 纳曲酮预处理 15 分钟后重新测定。
芬太尼、卡芬太尼和海洛因剂量依赖性地增加了与芬太尼相关的杠杆上的反应,并降低了杠杆按压的速度。卡芬太尼和海洛因分别比芬太尼强约 10 倍和弱约 10 倍,分别在与芬太尼相关的杠杆上引起 >80%的反应。0.1 mg/kg 纳曲酮预处理导致芬太尼和海洛因但不卡芬太尼的剂量-效应曲线显著右移。
与芬太尼和海洛因相比,纳曲酮对卡芬太尼辨别刺激作用的减弱效果的差异表明,卡芬太尼发挥其辨别刺激作用的方式可能与其他阿片类药物不同。需要进一步评估卡芬太尼与其他阿片类药物之间潜在的药理学和行为学差异,特别是在毒性方面。